Sign in
CompletedNo phase

Clinical Study on Monitoring the Plasma Concentration of Ceftazidime-Avibactam in Critically Ill Patients

Key facts

Who runs it
First Affiliated Hospital of Zhejiang University
Where
China1 site in 1 countryChoose a country to see its sites
Trial code
Status
Completed
People taking part
33 people enrolled
Started
1 Jun 2021
Ended
20 Dec 2023
Type of study
Observational
Treatments tested
  • Ceftazidime-avibactam
Record updated
10 September 2026

Who can take part

Age
18 years and older
Sex
Women and men
Healthy volunteers
Cannot take part
Show the full registry criteria (7)Hide the full registry criteria

Who can take part

  • Critically ill patients with severe sepsis(CRO infections) and treated with CAZ-AVI(culture-confirmed CRO susceptible to CAZ-AVI)
  • Age ≥ 18 years
  • Expected ICU stay ≥48 hours
  • Hemoglobin >70 g/L during the pharmacokinetic blood-sampling period;
  • The patient or authorized persons agree and sign the informed consent

Who cannot take part

  • Expected ICU stay <48 hours
  • Pregnant woman

Where is this trial?

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

This prospective observational study is conducted at the First Affiliated Hospital of Zhejiang University School of Medicine from June 1, 2021 to January 1, 2024. The study aims to characterize the population pharmacokinetics of ceftazidime (CAZ) and avibactam (AVI) in critically ill patients receiving ceftazidime-avibactam (CAZ-AVI), including patients with and without renal replacement therapy (RRT). Plasma concentrations of CAZ and AVI will be measured after the first-dose and steady-state administrations. Population pharmacokinetic and pharmacokinetic/pharmacodynamic target-attainment analyses will be performed to explore dosing strategies according to renal function and RRT status.

Treatments tested

  • Ceftazidime-avibactam

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Record updated
10 September 2026